Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Interest Coverage Ratio: 2012-2025

Historic Interest Coverage Ratio for Fennec Pharmaceuticals (FENC) over the last 5 years, with Sep 2025 value amounting to -0.32.

  • Fennec Pharmaceuticals' Interest Coverage Ratio rose 93.64% to -0.32 in Q3 2025 from the same period last year, while for Sep 2025 it was -1.70, marking a year-over-year decrease of 506.35%. This contributed to the annual value of 0.63 for FY2024, which is 116.77% up from last year.
  • Fennec Pharmaceuticals' Interest Coverage Ratio amounted to -0.32 in Q3 2025, which was up 92.99% from -4.60 recorded in Q2 2025.
  • Fennec Pharmaceuticals' Interest Coverage Ratio's 5-year high stood at 13.29 during Q1 2024, with a 5-year trough of -1,230.75 in Q1 2021.
  • For the 3-year period, Fennec Pharmaceuticals' Interest Coverage Ratio averaged around -1.75, with its median value being -1.99 (2023).
  • Examining YoY changes over the last 5 years, Fennec Pharmaceuticals' Interest Coverage Ratio showed a top increase of 301.26% in 2024 and a maximum decrease of 327.17% in 2024.
  • Fennec Pharmaceuticals' Interest Coverage Ratio (Quarterly) stood at -75.87 in 2021, then grew by 12.51% to -10.47 in 2022, then soared by 81.03% to -1.99 in 2023, then soared by 51.34% to -0.97 in 2024, then soared by 93.64% to -0.32 in 2025.
  • Its last three reported values are -0.32 in Q3 2025, -4.60 for Q2 2025, and -1.36 during Q1 2025.